This week in IP: Pfizer allows COVID pill copies, USPTO publishes TMA rules, and more By Max Walters & Rani Mehta & Rory O’Neill & Sukanya Sarkar November 19 2021
This week in IP: Nokia hits 4,000 5G SEP families, Moderna and NIH debate patent creds,... By Max Walters & Rani Mehta & Rory O’Neill & Sukanya Sarkar November 12 2021
This week in IP: Spain adopts Copyright Directive, USPTO head grants first Arthrex revi... By Max Walters & Patrick Wingrove & Rani Mehta & Rory O’Neill November 05 2021
This week in IP: Slovenia deposits UPC ratification, IV sues three car makers, and more By Max Walters & Patrick Wingrove & Rani Mehta & Rory O’Neill & Sukanya Sarkar October 22 2021
UK FRAND update: three judgments that change the dynamic of SEP disputes By William Warne November 17 2021
Patent paradox: using global strategy to protect country-specific assets By April Abele Isaacson November 05 2021
This week in IP: Fenwick & West pays tribute to co-founder, China targets ‘IP powerhous... By Max Walters & Patrick Wingrove & Rani Mehta & Rory O’Neill & Sukanya Sarkar October 15 2021
This week in IP: UKIPO appoints new chair, Koh and Kanter face Senate hearings, and more By Max Walters & Patrick Wingrove & Rani Mehta & Rory O’Neill & Sukanya Sarkar October 08 2021
This content is from: Patents Apple to pay UK court’s FRAND rate, escapes sales ban By Rory O’Neill November 03 2021
This content is from: Patents Carpmaels escapes €1bn claim in BASF patent row By Max Walters October 30 2021
This content is from: Patents DABUS around the world: AI inventorship debate far from over By Ed White October 25 2021
This content is from: IP Strategy Black lawyers: say yes to challenges and ‘be the first’ By Max Walters October 23 2021
This content is from: Patents UK patent attorneys hopeful over proposed qualification overhaul By Max Walters October 18 2021
